(Updated - April 30, 2024 4:46 AM EDT)

Stifel analyst Paul Matteis initiates coverage on Contineum Therapeutics (NASDAQ: CTNM) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE